SKIPTAN

Skiptan Pty Ltd is an Australian private investment company and family office acting as the investment vehicle for the P&M Meurs Family Trust, associated with prominent investor Peter Meurs. The company is a major shareholder and financial backer of several Australian biotechnology companies, most notably Dimerix Limited (ASX: DXB) and AdAlta Limited (ASX: 1AD). In July 2026, Skiptan entered into a $10 million unsecured loan facility with Dimerix to support the clinical development of its kidney disease programs, which was later expanded into a larger A$34 million syndicate in September 2026. Through these strategic investments and non-dilutive funding facilities, Skiptan plays a critical role in advancing late-stage clinical trials and pipeline expansion in the life sciences sector.